Informatie:
Fout:
ID
34339
Beschrijving
Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01080768
Link
https://clinicaltrials.gov/show/NCT01080768
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hypertension NCT01080768
Eligibility Hypertension NCT01080768
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT01080768
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
patients (male or female) with hypertension aged between 18-75 yrs.
boolean
ID.2
Item
patients not treated with amlodipine or no amlodipine in previous 1 year.
boolean
ID.3
Item
post-menopausal females
boolean
ID.4
Item
patients unable to switch from prior hypertensive medication.
boolean
ID.5
Item
severe hypertension.
boolean
ID.6
Item
pregnant or nursing females.
boolean
ID.7
Item
patients with type 1 or type 2 diabetes mellitus
boolean
ID.8
Item
history of immunodeficiency diseases, including a positive human immunodeficiency virus (hiv) (enzyme-linked immunosorbent assay [elisa] and western blot) test result.
boolean
ID.9
Item
a positive hepatitis b surface antigen (hbsag) or hepatitis c test result.
boolean
ID.10
Item
other protocol-defined inclusion/exclusion criteria are applied
boolean